focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

Share Price Information for Citigroup Inc (13PH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 118.84
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 118.84
High: 0.00
Low: 0.00
Prev. Close: 118.84
13PH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - offeree

25 Jun 2021 15:04

RNS Number : 2102D
Citigroup Inc
25 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Citigroup Inc.

Company dealt in

Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

 24 June 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,803,778 2.95%

512,735 0.40%

(2) Derivatives (other than options)

7,535 0.01%

36,368 0.03%

(3) Options and agreements to purchase/sell

 

Total

3,811,313 2.95%

549,103 0.43%

       

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

Purchase

2,387

 Highest 232.76 Lowest 232.55

Sale

453

Highest 233.32 Lowest 230.63

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

 

 

 

 

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

25 June 2021

Contact name

Damian Flanagan

Telephone number

+ 44 (0) 2890 409 676

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUVRSRASUNUAR
12
Date   Source Headline
20th May 20213:10 pmRNSForm 8.3 - offeree
19th May 20212:50 pmRNSForm 8.3 - offeree
18th May 20213:01 pmRNSForm 8.3 - offeree
17th May 20212:41 pmRNSForm 8.3 - offeree
14th May 20213:58 pmRNSForm 8.3 - offeree
13th May 20213:23 pmRNSForm 8.3 - offeree
12th May 20213:50 pmRNSForm 8.3 - offeree
11th May 20213:59 pmRNSForm 8.3 - offeree
10th May 20213:49 pmRNSForm 8.3 - offeree
7th May 20212:35 pmRNSForm 8.3 - offeree
6th May 20213:54 pmRNSForm 8.3 - offeree
5th May 20214:29 pmRNSForm 8.3 - offeree
4th May 20213:06 pmRNSForm 8.3 - Willis Towers Watson PLC
4th May 20213:04 pmRNSForm 8.3 - Willis Towers Watson plc
4th May 20212:56 pmRNSForm 8.3 - offeree
4th May 202111:22 amRNSForm 8 (DD) - offeree
30th Apr 20212:29 pmRNSForm 8 (DD) - offeree
29th Apr 20213:13 pmRNSForm 8.3 - offeree
28th Apr 20213:05 pmRNSForm 8.3 - offeree
27th Apr 20213:10 pmRNSForm 8.3 - offeree
27th Apr 20217:41 amRNSForm 8.3 - offeree-Amendment
26th Apr 20213:04 pmRNSForm 8.3 - [offeree]
23rd Apr 20213:17 pmRNSForm 8.3 - offeree
22nd Apr 20213:22 pmRNSForm 8.3 - offeree
22nd Apr 202112:01 pmRNSForm 8.3 - offeree - Amendment
22nd Apr 202111:49 amRNSForm 8.3 - offeree - Amendment
21st Apr 20214:25 pmRNSForm 8.3 - offeree
20th Apr 20213:43 pmRNSForm 8.3 - offeree
19th Apr 20214:58 pmRNSForm 8.3 - offeree
16th Apr 20214:40 pmRNSForm 8.3 - offeree
15th Apr 20213:22 pmRNSForm 8.3 - offeree
14th Apr 20213:38 pmRNSForm 8.3 - offeree
13th Apr 20211:37 pmRNSForm 8.3 - offeree
12th Apr 20213:45 pmRNSForm 8.3 - offeree
9th Apr 20213:19 pmRNSForm 8.3 - offeree
8th Apr 20213:46 pmRNSForm 8.3 - offeree
7th Apr 20213:58 pmRNSForm 8.3 - offeree
6th Apr 20213:33 pmRNSForm 8.3 - offeree
6th Apr 20219:40 amRNSForm 8.3 - offeree
1st Apr 20214:40 pmRNSForm 8.3 - offeree
31st Mar 20213:56 pmRNSForm 8.3 - offeree
30th Mar 20215:13 pmRNSForm 8.3 - [offeree]
29th Mar 20212:47 pmRNSForm 8.3 - [offeree]
29th Mar 20217:00 amRNSForm 8.3 - [offeror]
26th Mar 20215:19 pmRNSForm 8.3 - [Offeror]
30th Apr 202012:25 pmRNSArticle 8
27th Apr 202010:09 amRNSDelisting of Notes Series EMTN6619
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.